Absence of Biomarker Profiles Typical of Alzheimer's Disease

Findings highlight the need to continue developing new disease-modifying treatments with different mechanisms of action for patients with Alzheimer's disease.

Related Keywords

Sweden ,Solna ,Stockholm ,Karolinska Institutet ,Janna Rosenberg ,Miia Kivipelto ,Karolinska University Hospital Medical Unit Aging Memory ,Karolinska Institute ,Karolinska University Hospital ,Janssen Pharmaceutical Companies Of Johnson ,Karolinska University Hospital Memory ,Janssen Pharmaceutica ,Janssen Pharmaceutical Companies ,Press Office ,Neurodegeneration Classification ,Anti Amyloid Treatment ,Memory Clinic ,Neuroscience Newsletter ,